{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T18:00:06Z","timestamp":1761933606922,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":4148,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1016\/j.bbmt.2003.08.002","type":"journal-article","created":{"date-parts":[[2003,12,13]],"date-time":"2003-12-13T06:44:37Z","timestamp":1071297877000},"page":"753-759","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Reduced-intensity transplantation for patients with myelodysplastic syndrome achieves durable remission with less graft-versus-host disease"],"prefix":"10.1016","volume":"9","author":[{"given":"Geoffrey W","family":"Chan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francine M","family":"Foss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas K","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kellie","family":"Sprague","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth B","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2003.08.002_BIB1","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1056\/NEJM199905273402107","article-title":"Myelodysplasia","volume":"340","author":"Heaney","year":"1999","journal-title":"N Engl J Med."},{"key":"10.1016\/j.bbmt.2003.08.002_BIB2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","article-title":"Proposals for the classification of the myelodysplastic syndromes","volume":"51","author":"Bennett","year":"1982","journal-title":"Br J Haematol."},{"key":"10.1016\/j.bbmt.2003.08.002_BIB3","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1046\/j.1365-2141.2000.02200.x","article-title":"Haematopoietic stem cell transplantation for patients with myelo-dysplastic syndromes and secondary acute myeloid leukaemias","volume":"110","author":"de Witte","year":"2000","journal-title":"Br J Haematol."},{"key":"10.1016\/j.bbmt.2003.08.002_BIB4","article-title":"Nonmyeloablative stem cell transplant in AML, ALL, and MDS","volume":"96","author":"Rezvani","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2003.08.002_BIB5","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/sj.bmt.1703215","article-title":"A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome","volume":"28","author":"Kroger","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2003.08.002_BIB6","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s00277-003-0654-9","article-title":"Allogeneic stem cell transplantation after a fludarabine\/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia","volume":"82","author":"Kroger","year":"2003","journal-title":"Ann Hematol."},{"key":"10.1016\/j.bbmt.2003.08.002_BIB7","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2003.08.002_BIB8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF01695914","article-title":"Adjusted-dose continuous-infusion cyclosporin A to prevent graft-versus-host disease following allogeneic bone marrow transplantation","volume":"68","author":"Miller","year":"1994","journal-title":"Ann Hematol."},{"key":"10.1016\/j.bbmt.2003.08.002_BIB9","first-page":"3671","article-title":"Report of an international working group to standardize response criteria for myelodysplastic syndromes","volume":"96","author":"Cheson","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2003.08.002_BIB10","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1046\/j.1365-2141.1997.1112925.x","article-title":"IBMTR Severity Index for grading acute graft-versus-host disease","volume":"97","author":"Rowlings","year":"1997","journal-title":"Br J Haematol."},{"key":"10.1016\/j.bbmt.2003.08.002_BIB11","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1200\/JCO.1988.6.10.1562","article-title":"Regimen-related toxicity in patients undergoing bone marrow transplantation","volume":"6","author":"Bearman","year":"1988","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.bbmt.2003.08.002_BIB12","first-page":"1997","article-title":"Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia","volume":"100","author":"Sierra","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2003.08.002_BIB13","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1182\/blood-2002-02-0400","article-title":"Evidence for a graft-versus-leukemia effect after allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning in acute myelogenous leukemia and myelodysplastic syndromes","volume":"100","author":"Martino","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2003.08.002_BIB14","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1182\/blood.V94.9.3234","article-title":"Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation","volume":"94","author":"Childs","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2003.08.002_BIB15","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1200\/JCO.1998.16.8.2817","article-title":"Transplant-lite","volume":"16","author":"Khouri","year":"1998","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.bbmt.2003.08.002_BIB16","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.V91.3.756","article-title":"Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases","volume":"91","author":"Slavin","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2003.08.002_BIB17","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/stem.140473","article-title":"The immunopathophysiology of acute graft-versus-host-disease","volume":"14","author":"Ferrara","year":"1996","journal-title":"Stem Cells"},{"key":"10.1016\/j.bbmt.2003.08.002_BIB18","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1126\/science.285.5426.412","article-title":"Prevention of graft versus host disease by inactivation of host antigen-presenting cells","volume":"285","author":"Shlomchik","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bbmt.2003.08.002_BIB19","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1182\/blood.V99.7.2586","article-title":"Campath-1G causes rapid depletion of circulating host dendritic cells (DCs) before allogeneic transplantation but does not delay donor DC reconstitution","volume":"99","author":"Klangsinsirikul","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2003.08.002_BIB20","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1046\/j.1365-2141.2000.01879.x","article-title":"Preliminary experience of allogeneic stem cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH conditioning","volume":"108","author":"Cull","year":"2000","journal-title":"Br J Haematol."},{"key":"10.1016\/j.bbmt.2003.08.002_BIB21","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1423-0410.2000.tb00062.x","article-title":"Extracorporeal photochemotherapy\u2014present and future","volume":"78","author":"Knobler","year":"2000","journal-title":"Vox Sang."},{"key":"10.1016\/j.bbmt.2003.08.002_BIB22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1054\/blre.2001.0155","article-title":"Extracorporeal photopheresis","volume":"15","author":"Oliven","year":"2001","journal-title":"Blood Rev."},{"key":"10.1016\/j.bbmt.2003.08.002_BIB23","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1182\/blood.V96.7.2426","article-title":"Extracorporeal photochemotherapy in the treatment of severe steroid- refractory acute graft-versus-host disease","volume":"96","author":"Greinix","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2003.08.002_BIB24","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1182\/blood.V98.5.1622","article-title":"Immunomodulatory effects of extracorporeal photochemotherapy in patients with extensive chronic graft-versus-host disease","volume":"98","author":"Alcindor","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2003.08.002_BIB25","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S1083-8791(03)70006-8","article-title":"Persistence of host dendritic cells after transplantation is associated with graft-versus-host disease","volume":"9","author":"Chan","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2003.08.002_BIB26","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1083-8791(03)80106-4","article-title":"Modulation of host dendritic cells by extracorporeal photopheresis in an allogeneic bone marrow transplant conditioning regimen","volume":"9","author":"Chan","year":"2003","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879103002908?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879103002908?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:57:08Z","timestamp":1761055028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879103002908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["S1083879103002908"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2003.08.002","relation":{},"ISSN":["1083-8791"],"issn-type":[{"type":"print","value":"1083-8791"}],"subject":[],"published":{"date-parts":[[2003,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduced-intensity transplantation for patients with myelodysplastic syndrome achieves durable remission with less graft-versus-host disease","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2003.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}